Methylene Blue Against Vivax Malaria in Ethiopia , ClinicalTrials.gov NCT02696928 (withdrawn) (2016)

Government Record · Heidelberg University (sponsor) · April 2016

Heidelberg University (sponsor), 2016-04: Registered pilot trial of methylene blue-based radical cure for P. vivax in Ethiopia that was withdrawn before enrolment (actual enrolment 0).

Feasibility of Methylene Blue-based Combination Therapy in the Radical Treatment of Adult Patients With Plasmodium Vivax Malaria in Ethiopia: a Randomised Controlled Pilot Trial

Registry record field

Heidelberg University (sponsor), 2016-04: Registered pilot trial of methylene blue-based radical cure for P. vivax in Ethiopia that was withdrawn before enrolment (actual enrolment 0). Record field (official title) transcribed from the API v2 record. Status WITHDRAWN, enrollment 0 (actual), estimated completion January 2018, no results. Bearing recorded as CONTRADICTS only in the narrow sense that the planned human vivax test never happened: the vivax evidence in humans is absent, not negative. Registered, withdrawn, no results. Study type: other.